Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan · Delayed Price · Currency is TWD 49.25
+0.65 (1.34%)
At close: Apr 17, 2026
Pet Pharm Biotech Market Cap
Pet Pharm Biotech has a market cap or net worth of 2.83 billion as of April 20, 2026. Its market cap has increased by 2.69% in one year.
Market Cap
2.83B
Enterprise Value
2.44B
Revenue
222.03M
Ranking
n/a
PE Ratio
107.61
Stock Price
49.25
Market Cap Chart
Since July 26, 2024, Pet Pharm Biotech's market cap has increased from 1.39B to 2.83B, an increase of 103.50%. That is a compound annual growth rate of 50.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 2.82B | -21.36% |
| Dec 31, 2025 | 3.58B | 116.51% |
| Dec 31, 2024 | 1.66B | 18.92% |
| Jul 26, 2024 | 1.39B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Feei Cherng Develop Technology | 2.86B |
| Kaofu Chemical | 2.84B |
| Chime Ball Technology | 2.83B |
| MetaTech (AP) | 2.83B |
| Taiwan Auto-Design Co. | 2.81B |
| Joules Miles | 2.81B |
| Taiwan Takisawa Technology | 2.81B |
| HeXun Biosciences | 2.80B |